14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $60.86 $75.66 Wednesday, 1st May 2024 CYTK stock ended at $63.37. This is 3.34% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 4.70% from a day low at $61.37 to a day high of $64.26.
90 days $60.86 $84.05
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
Jan 20, 2021 $20.75 $20.97 $19.85 $19.98 957 911
Jan 19, 2021 $19.04 $19.97 $18.91 $19.89 835 934
Jan 15, 2021 $19.85 $20.46 $18.89 $18.96 743 105
Jan 14, 2021 $19.50 $20.06 $19.00 $19.80 1 767 248
Jan 13, 2021 $19.65 $19.80 $19.23 $19.27 513 645
Jan 12, 2021 $19.93 $20.15 $19.55 $19.68 512 153
Jan 11, 2021 $21.73 $21.91 $19.87 $20.00 891 082
Jan 08, 2021 $21.77 $22.25 $20.98 $21.55 579 759
Jan 07, 2021 $21.36 $21.73 $20.95 $21.53 2 004 878
Jan 06, 2021 $19.68 $21.63 $19.68 $21.31 888 168
Jan 05, 2021 $19.44 $20.36 $19.25 $19.88 677 043
Jan 04, 2021 $20.79 $20.79 $19.23 $19.56 697 613
Dec 31, 2020 $20.31 $21.09 $20.16 $20.78 786 388
Dec 30, 2020 $20.64 $21.10 $20.02 $20.36 967 518
Dec 29, 2020 $21.07 $21.28 $20.26 $20.60 539 631
Dec 28, 2020 $20.80 $21.50 $20.50 $20.95 580 549
Dec 24, 2020 $21.10 $21.65 $20.93 $20.94 307 178
Dec 23, 2020 $20.28 $21.07 $19.85 $20.98 393 265
Dec 22, 2020 $20.37 $20.91 $20.08 $20.36 648 088
Dec 21, 2020 $20.73 $21.09 $20.20 $20.42 813 266
Dec 18, 2020 $21.17 $21.86 $20.93 $21.22 2 777 794
Dec 17, 2020 $21.08 $21.35 $20.87 $21.10 770 112
Dec 16, 2020 $21.14 $21.39 $20.04 $21.00 594 983
Dec 15, 2020 $21.31 $21.42 $19.84 $21.00 953 246
Dec 14, 2020 $20.01 $21.66 $20.00 $21.24 1 653 155
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT